Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-26 07:19:39 UTC |
---|
Update Date | 2016-11-09 01:21:27 UTC |
---|
Accession Number | CHEM036219 |
---|
Identification |
---|
Common Name | Lactosylceramide (d18:1/16:0) |
---|
Class | Small Molecule |
---|
Description | |
---|
Contaminant Sources | |
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
LacCer(d18:1/16:0) | ChEBI | N-(Hexadecanoyl)-1-b-lactosyl-sphing-4-enine | ChEBI | 1-O-(4-O-b-D-Galactopyranosyl-b-D-glucopyranosyl)-ceramide | HMDB | 1-O-(4-O-beta-D-Galactopyranosyl-beta-glucopyranosyl)ceramide | HMDB | 1-O-(4-O-beta-D-Galactopyranosyl-beta-D-glucopyranosyl)-ceramide | HMDB | beta-D-Galactosyl-1,4-beta-D-glucosylceramide | HMDB | beta-D-Galactosyl-1,4-beta-D-glucosramide | HMDB | CDH | HMDB | CDW17 Antigen | HMDB | Cytopylin H | HMDB | D-Galactosyl-1,4-beta-D-glucosylceramide | HMDB | Gal-beta1->4GLC-beta1->1'cer | HMDB | LacCer | HMDB | Lactosyl ceramide (d18:1/16:0) | HMDB | Lactosyl-N-acylsphingosine | HMDB | Lactosylceramide | HMDB | N-(Hexadecanoyl)-1-beta-lactosyl-sphing-4-enine | HMDB | b-D-Galactosyl-(1->4)-b-D-glucosyl-(11)-N-hexadecanoylsphingosine | Generator, HMDB | β-D-Galactosyl-(1->4)-β-D-glucosyl-(11)-N-hexadecanoylsphingosine | Generator, HMDB | Lactosyl-N-palmitoyl-sphingosine | HMDB | N-(Hexadecanoyl)-1-β-lactosyl-sphing-4-enine | MetBuilder | Lactosylceramide(d18:1/16:0) | MetBuilder | N-(Hexadecanoyl)-1-β-lactosyl-sphingosine | MetBuilder | N-(Hexadecanoyl)-1-β-lactosyl-D-erythro-sphingosine | MetBuilder | N-(Hexadecanoyl)-1-β-lactosyl-4-sphingenine | MetBuilder | N-(Hexadecanoyl)-1-β-lactosyl-D-sphingosine | MetBuilder | N-(Hexadecanoyl)-1-β-lactosyl-sphingenine | MetBuilder | N-(Hexadecanoyl)-1-β-lactosyl-erythro-4-sphingenine | MetBuilder |
|
---|
Chemical Formula | C46H87NO13 |
---|
Average Molecular Mass | 862.182 g/mol |
---|
Monoisotopic Mass | 861.618 g/mol |
---|
CAS Registry Number | Not Available |
---|
IUPAC Name | N-[(2S,3R,4E)-1-{[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide |
---|
Traditional Name | N-[(2S,3R,4E)-1-{[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]hexadecanamide |
---|
SMILES | [H][C@@](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)(NC(=O)CCCCCCCCCCCCCCC)[C@]([H])(O)\C=C\CCCCCCCCCCCCC |
---|
InChI Identifier | InChI=1S/C46H87NO13/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-35(50)34(47-38(51)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)33-57-45-43(56)41(54)44(37(32-49)59-45)60-46-42(55)40(53)39(52)36(31-48)58-46/h27,29,34-37,39-46,48-50,52-56H,3-26,28,30-33H2,1-2H3,(H,47,51)/b29-27+/t34-,35+,36+,37+,39-,40-,41+,42+,43+,44+,45+,46-/m0/s1 |
---|
InChI Key | HLIJNIKSBCIDGO-QKLMXXKVSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as glycosyl-n-acylsphingosines. Glycosyl-N-acylsphingosines are compounds containing a sphingosine linked to a simple glucosyl moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Sphingolipids |
---|
Sub Class | Glycosphingolipids |
---|
Direct Parent | Glycosyl-N-acylsphingosines |
---|
Alternative Parents | |
---|
Substituents | - Glycosyl-n-acylsphingosine
- Fatty acyl glycoside
- Fatty acyl glycoside of mono- or disaccharide
- Alkyl glycoside
- Disaccharide
- Glycosyl compound
- O-glycosyl compound
- Fatty amide
- N-acyl-amine
- Oxane
- Fatty acyl
- Secondary carboxylic acid amide
- Secondary alcohol
- Carboxamide group
- Organoheterocyclic compound
- Polyol
- Oxacycle
- Carboxylic acid derivative
- Acetal
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Alcohol
- Organonitrogen compound
- Carbonyl group
- Organooxygen compound
- Primary alcohol
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | - beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-acylsphingosine (CHEBI:84758 )
|
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0gwf-0020037290-21dca1ca5fd13c57f9d9 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0089-0140259220-32ec01568647af1e8a9b | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-03di-1590725520-ad1444f1d366d916d1a3 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-03dl-0311045190-e794a5691906a48c5dcb | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0fhd-2412229030-6bae8d2533cd960334a2 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0h00-4910122000-20bac4f86c3c31786972 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-03di-0101002090-4b261587f6c949cba576 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-090u-5490031140-beeab0c6c4f152a1f39c | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-053j-2190100000-c3201464db308f2c1e3f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0w99-1500092550-ed0029181dab77c82234 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-01x0-3900043010-66d92e16856ff8a31054 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0ikc-3930132100-ee1522004d9ee686651d | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | HMDB0006750 |
---|
FooDB ID | FDB024055 |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
Chemspider ID | 24765743 |
---|
ChEBI ID | 84758 |
---|
PubChem Compound ID | 53477895 |
---|
Kegg Compound ID | C01290 |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | 1. Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. |
|
---|